More on HROW

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-39.4% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Harrow Health (NQ:HROW)
Delayed: 27.28 -1.47 (5.11%)
Prev. Close $28.75  
Open$28.59 
52 Wk High$ 
52 Wk Low$ 
Day High$28.67 
Day Low$27.13 
P/E N/A  
EPS$ 
Volume560,469 

Friends, Peers and Foes (?): AFRM, AMPX, CBZ, CRDO, CVNA (more...)

Oct 5, 2026 07:32 AM Form 8-K HARROW, INC. For: Oct 01
Oct 5, 2026 07:01 AM Harrow acquires Tyrvaya nasal spray for dry eye in $100M deal
Oct 5, 2026 07:00 AM Harrow Closes Acquisition of TYRVAYA®
Sep 30, 2026 07:00 AM Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO
Sep 9, 2026 06:09 AM Leerink Starts Harrow Health (HROW) at Outperform
Aug 21, 2026 06:33 PM Form 144 HARROW, INC. Filed by: Shojaei Amir
Aug 20, 2026 07:04 AM Harrow study shows Iheezo cuts discomfort after eye injections
Aug 20, 2026 07:00 AM Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
Aug 17, 2026 05:48 PM Form 4 HARROW, INC. For: Aug 14 Filed by: Shojaei Amir
Aug 10, 2026 04:44 PM Harrow Health (HROW) Misses Q2 EPS by 35c
View All Articles

Entities mentioned with HROW

View All Entities